Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

BioCorRx (BICX) Minority Interest (2018 - 2025)

BioCorRx's Minority Interest history spans 8 years, with the latest figure at $720344.0 for Q3 2025.

  • For Q3 2025, Minority Interest rose 519.31% year-over-year to $720344.0; the TTM value through Sep 2025 reached $720344.0, up 519.31%, while the annual FY2024 figure was -$234812.0, 82.26% down from the prior year.
  • Minority Interest for Q3 2025 was $720344.0 at BioCorRx, up from -$389027.0 in the prior quarter.
  • Across five years, Minority Interest topped out at $720344.0 in Q3 2025 and bottomed at -$389027.0 in Q2 2025.
  • The 5-year median for Minority Interest is -$126191.0 (2023), against an average of -$108472.2.
  • The largest YoY upside for Minority Interest was 519.31% in 2025 against a maximum downside of 166.15% in 2025.
  • A 5-year view of Minority Interest shows it stood at -$117838.0 in 2021, then decreased by 6.3% to -$125257.0 in 2022, then fell by 2.86% to -$128834.0 in 2023, then plummeted by 82.26% to -$234812.0 in 2024, then soared by 406.77% to $720344.0 in 2025.
  • Per Business Quant, the three most recent readings for BICX's Minority Interest are $720344.0 (Q3 2025), -$389027.0 (Q2 2025), and -$245169.0 (Q1 2025).